PureHealth has launched the Abu Dhabi Health Research Centre (ADHRC), a unified clinical research division that brings together all research activities across its Abu Dhabi hospitals, primary care clinics, and advanced laboratories.
The centre was announced at the inaugural ADHRC Research Conference 2025 in Abu Dhabi, supported by the Department of Health – Abu Dhabi (DoH), which brought together global experts to advance collaboration in clinical research and scientific innovation.
This milestone strengthens Abu Dhabi’s position in global healthcare advancement and highlights PureHealth’s commitment to translational research, medical innovation, and precision medicine.
ADHRC unifies clinical research across 16 hospitals, a wide network of primary health clinics, and advanced laboratories in Abu Dhabi. Covering the full research lifecycle, from protocol design and patient recruitment to regulatory coordination, data analysis, and publication, the centre drives high-impact studies.
With over 100 active studies, more than 300 principal investigators, and a scientific team of over 700, ADHRC collaborates with government bodies, global biopharma, and leading academic institutions to deliver research aligned with Abu Dhabi’s healthcare priorities.
The announcement follows the successful ADHRC Research Conference 2025, the center’s first major public initiative, which brought together 350+ delegates from government, academia, healthcare, and global life sciences to explore breakthroughs in cell and gene therapy, rare diseases, neurofrontiers, longevity science, and regulatory innovation.
Dr. Noura Khamis Al Ghaithi Undersecretary- Abu Dhabi DoH
“Harnessing the collective strength of our ecosystem is central to Abu Dhabi’s vision of advancing healthcare through science and innovation. The establishment of the Abu Dhabi Research Centre marks an important milestone in consolidating our research capabilities and driving high-impact clinical studies that improve lives locally and globally. This initiative reaffirms DoH’s commitment to positioning Abu Dhabi as a global hub for life sciences. By empowering partners such as PureHealth to lead high-quality, ethically governed and impactful research, we are accelerating discovery and enhancing patient outcomes.”
Shaista Asif, Group Chief Executive Officer at PureHealth, said that, “The establishment of ADHRC marks a defining moment in the UAE’s healthcare journey. By consolidating our research capabilities under one unified center, we are building on PureHealth’s longstanding legacy in medical research to accelerate the development of breakthrough therapies, improve patient outcomes, and reinforce Abu Dhabi’s position as a global hub for healthcare innovation. This transformation is driven by scientific excellence, operational scale, and our unwavering commitment to enabling longer, healthier lives for all.”
ADHRC focuses on high-impact areas like personalized medicine, rare diseases, and cutting-edge healthcare technologies, with inpatient and the largest outpatient Clinical Trial Units in the Middle East, handling over 800 participant visits daily.
Backed by DoH grants and multiple UAE health awards, PureHealth continues to lead the nation’s clinical research, establishing ADHRC as a regional and global hub for clinical trials and scientific innovation.
